Hemillan, Josephine M.
HRN: 19-37-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2024
CEFUROXIME 1.5GM (VIAL)
03/16/2024
03/19/2024
IV
1.5grams
Q8 X 3 Days
S/P TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes